pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy
Advanced drug delivery systems often employ nanomaterials as carriers to deliver drugs to
desirable disease sites for enhanced efficacy. However, most systems have low drug …
desirable disease sites for enhanced efficacy. However, most systems have low drug …
Enhanced cellular internalization and on-demand intracellular release of doxorubicin by stepwise pH-/reduction-responsive nanoparticles
F Li, W Chen, B You, Y Liu, S Yang… - … Applied Materials & …, 2016 - ACS Publications
The efficient delivery of antitumor agents to tumor sites faces numerous obstacles, such as
poor cellular uptake and slow intracellular drug release. In this regard, smart nanoparticles …
poor cellular uptake and slow intracellular drug release. In this regard, smart nanoparticles …
A CD44-targeting programmable drug delivery system for enhancing and sensitizing chemotherapy to drug-resistant cancer
M Zhang, Y Ma, Z Wang, Z Han, W Gao… - … applied materials & …, 2019 - ACS Publications
Programmable drug delivery systems hold great promise to enhance cancer treatment.
Herein, a programmable drug delivery system using a chondroitin sulfate (CS)-based …
Herein, a programmable drug delivery system using a chondroitin sulfate (CS)-based …
A traceable, GSH/pH dual-responsive nanoparticles with spatiotemporally controlled multiple drugs release ability to enhance antitumor efficacy
N Wang, C Liu, W Yao, H Zhou, S Yu, H Chen… - Colloids and Surfaces B …, 2021 - Elsevier
Constructing highly efficient and multifunctional nanoparticles to overcome the multiple
challenges of targeted drug delivery is a new strategy urgently needed in tumor therapy …
challenges of targeted drug delivery is a new strategy urgently needed in tumor therapy …
Redox-and MMP-2-sensitive drug delivery nanoparticles based on gelatin and albumin for tumor targeted delivery of paclitaxel
K Zhou, Y Zhu, X Chen, L Li, W Xu - Materials Science and Engineering: C, 2020 - Elsevier
Tumor-responsive nanocarriers are highly valuable and demanded for smart anticancer
drug delivery, where a quick release of chemotherapeutic drugs in tumors is preferred …
drug delivery, where a quick release of chemotherapeutic drugs in tumors is preferred …
Tailor-made dual pH-sensitive polymer–doxorubicin nanoparticles for efficient anticancer drug delivery
Efficient delivery of therapeutics into tumor cells to increase the intracellular drug
concentration is a major challenge for cancer therapy due to drug resistance and inefficient …
concentration is a major challenge for cancer therapy due to drug resistance and inefficient …
pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy
Z Xu, D Yang, T Long, L Yuan, S Qiu, D Li, C Mu… - Carbohydrate …, 2022 - Elsevier
Abstract pH-Responsive nanoparticles (NPs) have emerged as an effective antitumor drug
delivery system, promoting the drugs accumulation in the tumor and selectively releasing …
delivery system, promoting the drugs accumulation in the tumor and selectively releasing …
Self-assembled pH and redox dual responsive carboxymethylcellulose-based polymeric nanoparticles for efficient anticancer drug codelivery
KF Liu, YX Liu, CX Li, LY Wang, J Liu… - … Biomaterials Science & …, 2018 - ACS Publications
To face the growing demand of polymeric nanoparticles with biocompatibility and a drug
release profile, in this work, a novel carboxymethylcellulose-based pH and redox dual …
release profile, in this work, a novel carboxymethylcellulose-based pH and redox dual …
Polymer− cisplatin conjugate nanoparticles for acid-responsive drug delivery
We report the synthesis of novel acid-responsive therapeutic nanoparticles (NPs) with sub-
100 nm size consisting of polymer− cisplatin conjugates. The uniqueness of these drug …
100 nm size consisting of polymer− cisplatin conjugates. The uniqueness of these drug …
pH/redox sequentially responsive nanoparticles with size shrinkage properties achieve deep tumor penetration and reversal of multidrug resistance
W Feng, M Zong, L Wan, X Yu, W Yu - Biomaterials Science, 2020 - pubs.rsc.org
Multidrug resistance (MDR) remains a serious impediment to successful tumor
chemotherapy. Despite considerable efforts to address MDR, limited approaches have been …
chemotherapy. Despite considerable efforts to address MDR, limited approaches have been …